RNA therapy reverses pathological cardiac remodeling, improving heart function and prolonging life.
cardiomyopathy
Posted inCardiology, Metabolism, New Drugs, Regulatory
Camzyos: First Specific Drug to Treat Hypertrophic Cardiomyopathy
Mavacamten by Bristol-Myers Squibb is a new breath for all patients with obstructive hypertrophic cardiomyopathy.
Posted inClinical Trials, Metabolism, Neuroscience, Rare/Orphan Diseases
Redasemtide: Universal Medicine for Regeneration of Any Tissue
Redasemtide as a lifesaver for the most devastating diseases, including stroke, osteoarthritis, cardiomyopathy, and bullous epidermolysis.